Interleukin 17 (IL-17) and interleukin 23 (IL-23) levels are modulated by compressive orthodontic forces in humans

被引:5
|
作者
Allgayer, Susiane [1 ]
de Menezes, Luciane Macedo [2 ]
Batista, Eraldo L., Jr. [3 ]
机构
[1] Assoc Brasileira Odontol ABORS, Dept Orthodont, Rua Furriel Luis de Vargas 134, BR-90619900 Porto Alegre, RS, Brazil
[2] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Dept Orthodont, Ave Ipiranga 6681, BR-90619900 Porto Alegre, RS, Brazil
[3] Univ Manitoba, Coll Dent, Fac Hlth Sci, Dept Diagnost & Surg Sci,Div Periodont,Dept Oral, Winnipeg, MB R3E 0W2, Canada
关键词
Biologic marker; Interleukin; Interleukin-17; Maxillary expansion; Orthodontic appliances; Th17; cells; GINGIVAL CREVICULAR FLUID; PERIODONTAL-LIGAMENT; TOOTH MOVEMENT; CELL-DIFFERENTIATION; ROOT RESORPTION; TH17; CELLS; EXPRESSION; CYTOKINES; KINETICS; SITES;
D O I
10.1016/j.ejwf.2019.06.001
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: The purpose of the investigation was to evaluate whether the application of compression forces exerted on the periodontal ligament during orthodontic movement is reflected at the level of interleukin (IL)-17 and IL-23. Materials and methods: The gingival crevicular fluid (GCF) samples from the compression sites of 32 molars from 16 patients prescribed with modified Hyrax appliance were collected. The GCF were analyzed for IL-17, IL-23, and IL-1 beta (Control) at baseline and at 1, 7, and 14 days of active wear of the appliance. Results: Orthodontic forces resulted in increased levels of IL-17 and IL-23 in the GCF, which were statistically significant at 7 days of force application at compression sites. At day 14, levels decreased to baseline; IL-1 beta levels (positive control) were more elevated at all times after force application. IL-17 and IL-23 levels were significantly lower than IL-1D, and undetectable in some samples. Conclusion: Upregulation of IL-17 and IL-23 occurred in response to the force application in compression sites. Monitoring the levels of inflammatory mediators might be a clinically useful procedure, as they may help to define optimal forces to produce the most rapid tooth movement. (C) 2019 World Federation of Orthodontists.
引用
收藏
页码:148 / 152
页数:5
相关论文
共 50 条
  • [21] EXPRESSION LEVELS OF IL-17, IL-22 AND IL-23 RECEPTORS IN FOUR OSTEOBLAST MODELS AND THE EFFECTS OF IL-17, IL-22 AND IL-23 ON OSTEOBLASTS
    Zhang, J. -R.
    Dai, S. -M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 627 - 628
  • [22] Plasma levels of IL-17 and IL-23 in the patients with Multiple Sclerosis
    Yusefipour, Gholam Ali
    Sarvestani, Eskandar Kamali
    Jamebozorgi, Khosro
    Sharifian, Maryam
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 673 - 674
  • [23] IL-23/IL-17 biology and therapeutic considerations
    Dong, Chen
    JOURNAL OF IMMUNOTOXICOLOGY, 2008, 5 (01) : 43 - 46
  • [24] The IL-23–IL-17 axis in inflammatory arthritis
    Erik Lubberts
    Nature Reviews Rheumatology, 2015, 11 : 415 - 429
  • [25] Role of IL-17 and IL-23 in Septic Shock
    Ward, Peter A.
    Bosmann, Markus
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S52 - S52
  • [26] IL-23 is important in IL-17 induction in tuberculosis
    Khader, SA
    Pearl, J
    Gilmartin, L
    Jelly-Gibbs, DM
    Ghilardi, N
    de Sauvage, FJ
    Cooper, AM
    FASEB JOURNAL, 2004, 18 (04): : A90 - A90
  • [27] The IL-23/IL-17 axis in psoriatic arthritis
    Suzuki, Erika
    Mellins, Elizabeth D.
    Gershwin, M. Eric
    Nestle, Frank O.
    Adamopoulos, Iannis E.
    AUTOIMMUNITY REVIEWS, 2014, 13 (4-5) : 496 - 502
  • [28] The effects of Malassezia in the activation of Interleukin (IL)-23/IL-17 axis in Psoriasis
    Fang, HuaLi
    Hou, YingDou
    Zhuang, Hui
    Wang, ChengHong
    NEW MICROBIOLOGICA, 2022, 45 (02): : 130 - 137
  • [29] EVALUATION OF SERUM LEVELS OF INTERLEUKIN(IL)-17A, IL-17B, IL-17C, IL-17F AND IL-23 LEVELS IN PSORIATIC ARTHRITIS
    Duruoz, M. T.
    Ucar, U.
    Guvenc, Y.
    Surmeli, Z. Sari
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 821 - 821
  • [30] PLASMA LEVELS OF IL-17 AND IL-23 IN IRANIAN PATIENTS WITH MULTIPLE SCLEROSIS
    Jamebozorgi, K.
    Tahvili, S.
    Sarvestani, E. Kamali
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 172 - 172